Status
Conditions
Treatments
About
The aim of the study is to compare between alpha-fetoproteine as a biological marker and between ultrasound and Doppler in prediction of morbid adherent placenta.
Full description
in pregnant women withe previous cesarean section, placenta previa and ultrasonographic finding of an abnormally adherent placenta dose maternal serum alpha-fetoprotein predict prenataly the presence of morbid adherent placenta accurately?
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
pregnant women with history of scarred uterus
Exclusion criteria
pregnant women with fetus with congenital anomalies
150 participants in 2 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal